Customizable Platform of Hardware Automation, Workflow Software and Real-Time Analytics Transforms Patient-Centered Care Across All Care Settings
November 30, 2017
MOUNTAIN VIEW, Calif.
Omnicell, Inc., (NASDAQ: OMCL) a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, announced the Company will be showcasing the industry’s most comprehensive and customizable platform of medication management automation solutions to optimize patient care from hospital to home at this year’s American Society of Health-System Pharmacists 2017 Midyear Meeting, to be held in Orlando, FL from December 3-7.
Omnicell is revolutionizing the patient medication experience through an autonomous approach to medication management that leverages hardware and software to improve workflow, real-time predictive intelligence to enhance decision-making, and performance-driven partnerships that drive success and satisfaction.
According to a recent survey of health system C-suite leaders, 95 percent of respondents estimate drug expenses to increase by at least 10 percent over the next five years, with 16 percent of respondents estimating drug prices will climb by 30 percent or more.1 By leveraging technology to improve inventory control and effective medication management methods, hospitals can find ways to offset the effects of higher drug prices without sacrificing quality care.
“As healthcare providers struggle to meet the increasing challenges of medication management, ensuring availability, affordability, safety, and adherence across all settings is imperative to positive patient outcomes,” said Joe Lynch, vice president, Marketing at Omnicell. “Omnicell empowers our global healthcare partners to integrate and automate medication and supply management through hardware automation, workflow software and real-time predictive analytics that are transforming patient-centered care.”
A broad range of Omnicell’s portfolio of solutions will be displayed in booth #1101, including:
Omnicell offers a full suite of technologies that enable both hospital and retail pharmacies to automate manual processes to optimize inventory, floor space, and clinical staff time, and to monitor medication distribution anomalies and chain of custody in real time. These technologies help prevent medication errors, provide greater inventory control and visibility, and increase security for controlled substances.
At ASHP, Omnicell is introducing the XR2 Automated Central Pharmacy System, a revolutionary new technology that more fully automates medication inventory management, allowing pharmacies with both centralized and decentralized models to make a meaningful shift from operational demands to clinical contributions that impact patient outcomes.
As a worldwide leader in IV compounding automation, Omnicell is the only company with a suite of solutions to fully automate IV preparation, including robotic hazardous and non-hazardous IV compounding, as well as semi-automated IV management systems. Omnicell’s sterile compounding portfolio is augmented by unique data services, applications support, and expertise that enables hospitals and health systems to help enhance safety, improve therapy, reduce cost, and facilitate compliance related to sterile compounding processes.
IVX Workflow, a cloud based compact all-in-one package designed for safe, accurate, and streamlined IV sterile compounding, and a new addition to Omnicell’s growing portfolio, will be featured at the exhibit.
Omnicell’s Performance Center offering helps hospitals deal with the challenge of safely and effectively managing medications across a health system through a unique approach that combines expert services and real-time software. This unique approach helps optimize pharmacy supply chain and drives improved performance of enterprise pharmacy operations by monitoring data across the health system and recommending actions to help reduce inventory spend, manage medication shortages and expiration risk, and locate medications across a health system.
Omnicell’s XT series provides fast, secure, and versatile automated dispensing systems for the hospital floor, emergency department and operating room in a wide array of configurations along with software-only solutions to help institutions provide safe, high-quality care. Omnicell dispensing systems create safer, more efficient pharmacy and nursing workflow while providing better security for medications. This automation is ideal for acute care sites, including patient care floors and operating rooms, and for non-acute care sites such as skilled nursing facilities, rehabilitation centers, and clinics.
With the opioid epidemic reaching epic proportions and 1 in 10 healthcare providers abusing drugs at some point, Omnicell can help facilities reduce the risks associated with drug diversion.2 Omnicell’s portfolio includes easy-to-use, web-based diversion analytics software, which integrates with automated dispensing cabinets and other Omnicell automation, and enables a more effective and efficient way to monitor for potential drug diversion.
Omnicell has a complete set of solutions to support medication adherence. The unprecedented portfolio includes medication synchronization software, multimed adherence packaging, and related automation for use in hospital, retail, and community pharmacies. These products help increase patient engagement and improve medication adherence, leading to better clinical and financial outcomes.
In addition to displaying a broad range of solutions in its booth, Omnicell will host several symposiums during the conference including:
Panel discussion titled, “The Predictive Pharmacy: Leveraging Predictive Intelligence” on Sunday, December 3 at 4:30 p.m.
Arpit Mehta, PharmD, MPH, System Pharmacy Manager, Inova Health System
Jim Toohey, RPh, former Executive Director of Pharmacy, Aultman Hospital
Ken Perez, Omnicell Vice President of Healthcare Policy, will be moderating
An Educational Symposium titled, “Extending Beyond-Use Dating and Batch Release Testing: Considerations for Your IV Room” on Tuesday, December 5 at 5:30 p.m.
The speaker will be Thomas C. Kupiec, PhD, President and CEO of ARL Bio Pharma, with John Barickman, Senior Executive IV Pharmacist Consultant for Omnicell, moderating.
1 “Premier Inc. C-Suite Survey: Healthcare Leaders Expanding Use of Generics, Educating Physicians on Therapeutic Alternatives to Control Drug Spending,” https://www.premierinc.com/premier-inc-c-suite-survey-healthcare-leaders-expanding-use-generics-educating-physicians-therapeutic-alternatives-control-drug-spending.
2 Davenport, Courtney. Aug. 19, 2014, PNLRE-Newsletter. Justice.org. N.p., 2015.